Bladder cancer is becoming increasingly prevalent, and in 2012 was reported as the 5th most common cancer in Europe. While cytology screening is commonplace for diagnosing bladder cancer, a recent ...

Oxford Gene Technology (OGT), The Molecular Genetics Company, is extending its portfolio of Cytocell® Pathology FISH probes with the addition of eight new probes. OGT offers the widest range of ...

Oxford Gene Technology (OGT), The Molecular Genetics Company, has launched its CE-IVD labelled Cytocell Aquarius® P16/3c/7c/17c Probe Kit, a cost-effective, ready-to-use fluorescence in situ ...

Oxford Gene Technology (OGT), The Molecular Genetics Company, is extending its portfolio of Cytocell® Pathology FISH probes with the addition of eight new probes. OGT offers the widest range of ...

Please use one of the following formats to cite this article in your essay, paper or report: APA. Oxford Gene Technology. (2019, June 19). OGT launches new, easy-to-use Cytocell FISH probes website.

Oxford Gene Technology expands Cytocell FISH probe portfolio for lung cancers: Oxfordshire, UK Thursday, September 15, 2016, 09:00 Hrs [IST] The molecular genetics company, Oxford Gene Technology (OGT ...

The Molecular Genetics Company, has launched its CE-IVD labelled Cytocell Aquarius ® 1p36/1q25 and 19q13/19p13 Deletion Probe Kit*, a cost-effective fluorescence in situ hybridisation (FISH) kit for ...

Cytocell Ltd. announced the availability of a new range of in vitro diagnostic tests to aid in detecting patients with Chronic Lymphocytic Leukaemia (CLL), a cancer of the lymphocytes. (Logo: http ...

Cytocell Ltd. today announced the availability of a new molecular cytogenetic test designed to identify the presence of gene rearrangements associated with a specific form of non-small-cell lung ...

OGT, A Sysmex Group Company, announces that IVDR-certification has been granted for eight CytoCell® fluorescence in situ hybridisation (FISH) probes important for patient management in haematological ...

Cytocell Ltd. today announced the availability of a new molecular cytogenetic test designed to identify the presence of gene rearrangements associated with a specific form of non-small-cell .